Cargando...
MON-LB115 Ready-To-Use Glucagon for the Prevention of Exercise-Induced Hypoglycemia in a Clinical Research Setting
OBJECTIVE: A mini-dose of a novel ready-to-use liquid stable glucagon (RTUG; Xeris Pharmaceuticals) was evaluated for the prevention of exercise-induced hypoglycemia (EIH) during and after moderate-to-high intensity aerobic exercise, in both a clinical research center (CRC) and outpatient setting. T...
Gardado en:
| Publicado en: | J Endocr Soc |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7208472/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.2183 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|